Treatment of Chronic Postherpetic Pain With Autologous Fat Grafting - A RCT
1 other identifier
interventional
40
1 country
1
Brief Summary
This randomized clinical trial investigates the possible beneficial effect of autologous fat grafting on postherpetic neuralgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2019
CompletedStudy Start
First participant enrolled
September 19, 2019
CompletedFirst Posted
Study publicly available on registry
September 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedMarch 22, 2023
March 1, 2023
2 years
August 27, 2019
March 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neuropathic pain [LEVEL OF PAIN]
Neuropathic Pain Symptom inventory (NPSI), Questionnaire. NPSI consists of 12 items in total: 10 items investigates differential symptoms descriptors and 2 items evaluate spontaneous and paroxysmal spontaneous pain. The tool evaluates mean pain intensity in the last 24h in a verbal numeric scale from zero (no pain) to 10 (worst imaginable pain). Total pain intensity score may be calculated by the sum of the 10 descriptors. The descriptors are: Burning, Squeezing, Pressure, Electric Shocks, Stabbing, Provoked by brushing. Provoked by pressure, Evoked by cold stimulation, Pins and needles, Tingling.
6 months
Secondary Outcomes (1)
Quality of life [QUALITY OF LIFE/ SATISFACTION]
6 months
Study Arms (2)
Intervention - Fat grafting
EXPERIMENTALThe participant will undergo the procedure under general anaesthesia. A small amount of fat (20-120 cc) will be harvested using liposuction, from the abdomen or the thighs. Randomized allocation will be made and when allocated to the intervention group, the fat will be purified using decanting and injected into the painful areas of skin.
Control - Saline
SHAM COMPARATORThe participant will undergo the procedure under general anaesthesia. A small amount of fat (20-120 cc) will be harvested using liposuction, from the abdomen or the thighs. Randomized allocation will be made and when allocated to the control group, the fat will be discarded and saline will be injected into the painful areas of skin.
Interventions
See arm descriptions.
Eligibility Criteria
You may qualify if:
- Age over 18
- Pain in area of former VZV-infection.
- Pain present over 3 months after reactivation of VZV and is present at least 4 days a week and of intensity \>3 on the VAS-scale
You may not qualify if:
- Psychiatric illness that could potentially affect the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Odense University Hospital
Odense, Funen, 5000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jens Ahm Sorensen, Prof
Professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The allocation will be masked. All patients will undergo the procedure under general anaesthesia. The randomized allocation will take place during surgery.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator, M.D, Dept. of Plastic and Reconstructive Surgery
Study Record Dates
First Submitted
August 27, 2019
First Posted
September 23, 2019
Study Start
September 19, 2019
Primary Completion
October 1, 2021
Study Completion
October 1, 2021
Last Updated
March 22, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share